Professor of Medicine (Oncology) and of Epidemiology and Population Health

Allison W. Kurian, M.D., M.Sc.

Bio

Allison W. Kurian, M.D., M.Sc. is a Professor of Medicine and of Epidemiology and Population Health at Stanford University School of Medicine. She received her medical degree from Harvard Medical School, trained as an intern and resident in Internal Medicine at the Massachusetts General Hospital, and completed her fellowship training in Medical Oncology along with a master’s degree in Epidemiology at Stanford University.Dr. Kurian’s research focuses on cancer genetics, precision oncology and the quality of cancer care at the population level. Current areas of investigation include innovative approaches to cascade genetic testing of the unaffected relatives of people with cancer, and the population-wide impact of advances in cancer genetics and genomics. Dr. Kurian's research has been supported by the National Cancer Institute, Susan G. Komen for the Cure, the American Society of Clinical Oncology, the California Breast Cancer Research Program, the Cancer Research and Prevention Foundation, the Robert Wood Johnson Foundation, the Breast Cancer Research Foundation and the BRCA Foundation.As Director of the Stanford Women’s Clinical Cancer Genetics Program, Dr. Kurian focuses her clinical practice on women at high risk for developing breast and gynecologic cancers. She is also a clinically active oncologist, treating patients diagnosed with breast cancer.

Clinical Focus

  • Cancer > Breast Cancer
  • Cancer Genetics
  • Breast Cancer Risk
  • Medical Oncology

Academic Appointments

Administrative Appointments

  • Chair, External Advisory Board, Basser Center for BRCA Research (2024 - 2024)
  • Chair, Germline Testing Measure Technical Expert Panel, American Society of Clinical Oncology (2024 - 2026)
  • Member, American Society of Clinical Oncology Guidelines Advisory Panel, Breast Cancer (2024 - 2028)
  • Working Group Member, Clinical Trial Diversity Action Plan, FDA Oncology Center of Excellence (2023 - 2024)
  • Panel on Guidelines for Germline Mutation Testing In Breast Cancer, American Society of Clinical Oncology (2022 - 2024)
  • External Advisory Board Member, Basser Center for BRCA Research (2021 - Present)
  • Associate Chief for Academic Affairs, Oncology Division, Stanford University (2020 - Present)
  • Co-Leader, Population Sciences Program, Stanford Cancer Institute (2020 - Present)
  • Steering Committee Member, CISNET Breast Cancer Working Group, National Cancer Institute (2020 - Present)
  • Advisory Committee Member, California Cancer Registry (2019 - Present)
  • Co-Investigator, Northern California Breast Cancer Family Registry (2018 - Present)
  • Specialty Editor, Breast Cancer Advisory Panel, American Society of Clinical Oncology (2016 - Present)
  • Working Group Member, ClinGen Hereditary Cancer Clinical Domain Working Group (2016 - Present)
  • Editorial Board; Special Editor for Hereditary Breast Cancer Syndromes, Cancer.Net, American Society of Clinical Oncology (2015 - Present)
  • Board of Directors Member, Facing Our Risk of Cancer Empowered (FORCE) (2015 - 2020)
  • External Advisory Board Member, Cancer Genomics Program, Princess Margaret Hospital Cancer Centre (2015 - 2016)
  • Lead Medical Oncology Investigator, Cancer Surveillance and Outcomes Research Team (CanSORT), University of Michigan School of Medicine (2014 - 2017)
  • Oncology Consultant, Breast Cancer Working Group, Cancer Intervention and Surveillance Modeling Network (CISNET), National Cancer Institute (2014 - Present)
  • Panel on Clinical Guidelines Development for Breast Cancer Risk Reduction, National Comprehensive Cancer Network (2013 - Present)
  • Director, Cancer Education Seminar, Stanford Division of Oncology (2013 - 2020)
  • Track Leader, Cancer Prevention and Epidemiology, Scientific Program Committee, American Society of Clinical Oncology (2013 - 2014)
  • Director, Stanford Women's Clinical Cancer Genetics Program (2012 - Present)
  • Scientific Program Committee, Quality Care Symposium, American Society of Clinical Oncology (2012 - 2015)
  • Advisory Committee, California HealthCare Foundation (2012 - 2014)
  • Board of Directors, Santa Clara County, American Cancer Society (2011 - 2016)
  • Scientific Program Committee, Cancer Prevention and Epidemiology, American Society of Clinical Oncology (2011 - 2014)
  • Scientific Program Committee, Genetic and Molecular Epidemiology, American Association for Cancer Research (2011 - 2012)
  • Panel on Clinical Guidelines Development for Genetic/ Familial Risk: Breast and Ovarian Cancer, National Comprehensive Cancer Network (2009 - Present)
  • Career Development Subcommittee, American Society of Clinical Oncology (2008 - 2011)
  • Program Committee, Professional Development, American Society of Clinical Oncology (2008 - 2011)
  • Associate Director, Stanford Clinical Cancer Genomics Program (2007 - Present)

Honors & Awards

  • Fellow, American Society of Clinical Oncology (FASCO) (2024)
  • Healthcare Hero Award, The Teal Foundation (2024)
  • Lecturer, Marvin Lipkin and Irving Weinstein Endowed Lecture in Cancer Prevention, Weill Cornell Medicine (2024)
  • Invited Researcher, Breast Cancer Research Foundation (2022)
  • Komen Scholar, Susan G. Komen for the Cure (2022)
  • Leadership Award, Susan G. Komen for the Cure (2022)
  • Impact Award, National Consortium of Breast Centers (2021)
  • Elected Member, American Society of Clinical Investigation (2020)
  • Exceptional Woman in Medicine, Castle Connolly (2019-2023)
  • Top Doctor, Castle Conolly (2019-2023)
  • Saul Rosenberg Faculty Teaching Award, Oncology Division, Stanford University School of Medicine (2019)
  • R01 CA225697, Principal Investigator, National Cancer Institute (2018)
  • Elizabeth Mayers Award for Outstanding Research, BRCA Foundation (2017)
  • Oncology Division Teaching Award, Stanford University School of Medicine (2014)
  • Suzanne Pride Bryan Award for Breast Cancer Research, Stanford University Cancer Institute (2013)
  • New Clinical Investigator Award, Stanford University Cancer Institute (2011)
  • Top 12 publications funded by the Epidemiology and Genomics Research Program, National Cancer Institute (2011)
  • Translational Research Award, California Breast Cancer Research Program (2010)
  • Jan Weimer Faculty Chair for Breast Oncology, Stanford University Cancer Institute (2008)
  • Physician Faculty Scholars Award, Robert Wood Johnson Foundation (2008)
  • Cornelius L. Hopper Research Abstract Award, California Breast Cancer Research Program (2007)
  • BIRCWH K12 Scholar Award, National Institutes of Health (2006)
  • Fellowship Award, California Breast Cancer Research Program (2005)
  • Fellowship Award, Cancer Research and Prevention Foundation (2005)
  • Young Investigator Award, American Society of Clinical Oncology (2005)
  • Merit Award, American Society of Clinical Oncology (2004)

Professional Education

  • Board Certification: American Board of Internal Medicine, Medical Oncology (2005)
  • Fellowship: Stanford University School of Medicine (2005) CA
  • Residency: Massachusetts General Hospital (2002) MA
  • Internship: Massachusetts General Hospital (2000) MA
  • Medical Education: Harvard Medical School (1999) MA
  • Maintenance of Certification, American Board of Internal Medicine, Medical Oncology (2015)
  • M.Sc., Stanford University, Epidemiology (2006)
  • B.A., Honors, Stanford University, Human Biology (1995)

Community and International Work